ACADIA Pharmaceuticals Inc ACAD
News
Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Ryan Reynolds Announces More to Parkinson’s® Campaign
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
Acadia Pharma's stock falls 15% after failed drug trial